Patents Assigned to Pulmonx
-
Publication number: 20070043350Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.Type: ApplicationFiled: July 28, 2006Publication date: February 22, 2007Applicant: PULMONxInventors: Peter Soltesz, Nikolai Aljuri, Ajit Nair
-
Patent number: 7141046Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.Type: GrantFiled: December 13, 2001Date of Patent: November 28, 2006Assignee: PulmonxInventors: Rodney A. Perkins, Peter P. Soltesz, Robert Kotmel
-
Publication number: 20060264772Abstract: Minimally invasive methods, systems and devices are provided for qualitatively and quantitatively assessing collateral ventilation in the lungs. In particular, collateral ventilation of a target compartment within a lung of a patient is assessed by advancement of a catheter through the tracheobronchial tree to a feeding bronchus of the target compartment. The feeding bronchus is occluded by the catheter and a variety of measurements are taken with the use of the catheter in a manner which is of low risk to the patient. Examples of such measurements include but are not limited to flow rate, volume and pressure. These measurements are used to determine the presence of collateral ventilation and to quantify such collateral ventilation.Type: ApplicationFiled: December 7, 2005Publication date: November 23, 2006Applicant: PULMONXInventors: Nikolai Aljuri, Anthony Wondka, George Surjan, Kirk Davis, Peter Soltesz, Rodney Perkins
-
Publication number: 20060162731Abstract: Methods, systems and devices are provided for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung and occluding various lung passageways with the use of occlusal stents. The occlusal stents are delivered with the use of an occlusal stent delivery system which is loaded with the occlusal stent with the use of an occlusal stent loading system.Type: ApplicationFiled: November 15, 2005Publication date: July 27, 2006Applicant: PULMONxInventors: Anthony Wondka, Peter Soltesz, Robert Kotmel, Nadia Matov, Thomas Crowder
-
Publication number: 20060135947Abstract: Improved methods, systems and devices for occluding body passageways, particularly lung passageways. Such occlusion is achieved with occlusal stents which are particularly suited for use in performing Endobronchial Volume Reduction (EVR) in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The present invention is likewise suitable for the treatment of bronchopleural fistula and potentially for other pulmonary diseases, such as hemoptysis and pneumothorax. The occlusal stents are delivered with the use of any suitable delivery system, particularly minimally invasive with instruments introduced through the mouth (endotracheally). A target lung tissue segment is isolated from other regions of the lung by deploying an occlusal stent into a target area of a lung passageway. A variety of different occlusal stent designs are provided to improve the performance and reliability of the delivered occlusal stent.Type: ApplicationFiled: November 15, 2005Publication date: June 22, 2006Applicant: PULMONxInventors: Peter Soltesz, Anthony Wondka, Jeffrey Lee, Robert Kotmel
-
Publication number: 20060095002Abstract: The present invention provides improved methods, systems, devices and kits for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung. Isolation is achieved by deploying an obstructive device in a lung passageway leading to the target lung tissue segment. Once the obstructive device is anchored in place, the segment can be aspirated through the device. This may be achieved by a number of methods, including coupling an aspiration catheter to an inlet port on the obstruction device and aspirating through the port.Type: ApplicationFiled: November 9, 2005Publication date: May 4, 2006Applicant: PULMONxInventors: Peter Soltesz, Robert Kotmel, Tony Wondka, Michael Reilly, Wally Buch
-
Patent number: 6997918Abstract: The present invention provides improved methods, systems, devices and kits for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung. Isolation is achieved by deploying an obstructive device in a lung passageway leading to the target lung tissue segment. Once the obstructive device is anchored in place, the segment can be aspirated through the device. This may be achieved by a number of methods, including coupling an aspiration catheter to an inlet port on the obstruction device and aspirating through the port.Type: GrantFiled: March 4, 2003Date of Patent: February 14, 2006Assignee: PulmonxInventors: Peter P. Soltesz, Robert Kotmel, Tony Wondka, Michael P. Reilly, Wally S. Buch
-
Publication number: 20050203483Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.Type: ApplicationFiled: April 12, 2005Publication date: September 15, 2005Applicant: PULMONxInventors: Rodney Perkins, Peter Soltesz, Robert Kotmel, Anthony Wondka
-
Patent number: 6878141Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.Type: GrantFiled: June 28, 2000Date of Patent: April 12, 2005Assignee: PulmonxInventors: Rodney A. Perkins, Peter P. Soltesz, Robert Kotmel, Anthony D. Wondka
-
Publication number: 20050061322Abstract: The invention relates to a method and an arrangement for reducing the volume of a patient's lung. A bronchial catheter (2) is introduced into a hyperexpanded lung area, and air is aspirated from there by means of an aspiration device (3). The associated segmental bronchus is then closed. According to the invention, the patient's spontaneous respiration is recorded by sensors (5), and aspiration of the air is carried out in synchrony with the patient's inhalation action. In order to prevent collapse of the associated segmental bronchus, a pressure generator is provided with which the associated segmental bronchus can be widened, by a compressed gas pulse, in synchrony with the aspiration. The pressure generator can be activated as a function of the aspirated air stream, which is monitored with a measuring device.Type: ApplicationFiled: November 3, 2004Publication date: March 24, 2005Applicant: PULMONxInventor: Lutz Freitag
-
Publication number: 20050015106Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.Type: ApplicationFiled: August 20, 2004Publication date: January 20, 2005Applicant: PULMONxInventors: Rodney Perkins, Peter Soltesz, Robert Kotmel
-
Publication number: 20040158228Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.Type: ApplicationFiled: January 26, 2004Publication date: August 12, 2004Applicant: PULMONxInventors: Rodney A. Perkins, Peter P. Soltesz, Robert Kotmel
-
Publication number: 20040073191Abstract: The present invention provides improved methods, systems, devices and kits for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung. Isolation is achieved by deploying an obstructive device in a lung passageway leading to the target lung tissue segment. Once the obstructive device is anchored in place, the segment can be aspirated through the device. This may be achieved by a number of methods, including coupling an aspiration catheter to an inlet port on the obstruction device and aspirating through the port.Type: ApplicationFiled: March 4, 2003Publication date: April 15, 2004Applicant: PULMONxInventors: Peter P. Soltesz, Robert Kotmel, Tony Wondka, Michael P. Reilly, Wally S. Buch
-
Patent number: 6709401Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.Type: GrantFiled: July 2, 2001Date of Patent: March 23, 2004Assignee: PulmonxInventors: Rodney A. Perkins, Peter P. Soltesz, Robert Kotmel
-
Patent number: 6585639Abstract: Apparatus, methods, and kits, are provided for use in combination with a conventional bronchoscope or other lung viewing scope. In particular, sheaths having an inflatable cuff at their distal end are provided to receive a viewing scope through a lumen thereof. The sheaths thus provide an inflatable cuff on a viewing scope assembly so that the scope can be used in procedures which require selective isolation of regions of a patient's lungs. In particular embodiments, the sheaths may include stop elements for properly positioning a viewing scope therein, pressure transducers for providing accurate lung pressure information during procedures, and the like. Methods for using and forming sheaths having inflatable cuffs are also described.Type: GrantFiled: October 27, 2000Date of Patent: July 1, 2003Assignee: PulmonxInventors: Robert Kotmel, Hiep Nguyen
-
Publication number: 20030051733Abstract: The present invention provides systems, methods, devices and kits for assessing the level of pulmonary disease in individual lung compartments. A lung compartment comprises a subportion of a lung, such as a lobe, a segment or a subsegment, for example. By measuring individual lung compartments, the level of disease of the pulmonary system may be more precisely defined by determining values of disease parameters reflective of individual subportions or compartments of a lung. Likewise, compartments may be separately imaged to provide further measurement information. Once individual compartments are characterized, they may be compared and ranked based on a number of variables reflecting, for example, level of disease or need for treatment. Such comparison may be aided by simultaneous display of such variables or images on a visual display. Further, the same tests may be performed on the lung as a whole or on both lungs and to determine the affect of the diseased lung compartments on the overall lung performance.Type: ApplicationFiled: September 10, 2002Publication date: March 20, 2003Applicant: PulmonxInventors: Robert Kotmel, Peter Soltesz, Anthony Wondka, Rodney Perkins
-
Publication number: 20030055331Abstract: Devices and methods are provided for acquiring and analyzing an image data file to generate diagnostic information reflecting an individual lung compartment. A lung compartment could be an entire lobe, a segment or a subsegment and beyond, hereinafter subsegments and beyond will be referred to simply as segments. Such analysis is used to assess the level of disease of individual lung compartments, both for quantification of the disease state and for determining the most appropriate treatment plan. This analysis allows the imaging technology to be used as a functional diagnostic tool as well as an anatomical diagnostic tool. To this end, dynamic data or images may also be acquired at specific points throughout the breathing cycle. Since air movement in and out of a lung compartment during the breathing cycle is a direct indicator of lung function in some diseases like emphysema, analysis of images during the breathing cycle will indicate levels of disease.Type: ApplicationFiled: September 11, 2002Publication date: March 20, 2003Applicant: PULMONxInventors: Robert Kotmel, Peter Soltesz, Anthony Wondka, Rodney Perkins
-
Patent number: 6527761Abstract: Methods, systems, devices and kits for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions using and comprising minimally invasive instruments introduced through the mouth (endotracheally) to isolate a target lung tissue segment from other regions of the lung and reduce lung volume. Isolation is achieved by deploying an obstructive device in a lung passageway leading to the target lung tissue segment. Once the obstructive device is anchored in place, the segment can be aspirated through the device. This may be achieved by a number of methods, including coupling an aspiration catheter to an inlet port on the obstruction device and aspirating through the port. Or, providing the port with a valve which allows outflow of gas from the isolated lung tissue segment during expiration of the respiratory cycle but prevents inflow of air during inspiration. In addition, a number of other methods may be used.Type: GrantFiled: October 27, 2000Date of Patent: March 4, 2003Assignee: Pulmonx, Inc.Inventors: Peter P. Soltesz, Robert Kotmel, Tony Wondka, Michael P. Reilly, Wally S. Buch
-
Publication number: 20020077593Abstract: Apparatus, systems, methods, and kits are provided for isolating a target lung segment and treating that segment, usually by drug delivery or lavage. The systems include at least a lobar or sub-lobar isolation catheter which is introduced beyond a second lung bifurcation (i.e., beyond the first bifurcation in a lobe of the lung) and which can occlude a bronchial passage at that point. An inner catheter is usually introduced through the isolation catheter and used in cooperation with the isolation catheter for delivering and/or removing drugs or washing liquids from the isolated lung region. Optionally, the inner catheter will also have an occluding member near its distal end for further isolation of a target region within the lung.Type: ApplicationFiled: February 11, 2002Publication date: June 20, 2002Applicant: PULMONXInventors: Rodney A. Perkins, Peter P. Soltesz, Robert Kotmel
-
Patent number: 6398775Abstract: Apparatus, systems, methods, and kits are provided for isolating a target lung segment and treating that segment, usually by drug delivery or lavage. The systems include at least a lobar or sub-lobar isolation catheter which is introduced beyond a second lung bifurcation (i.e., beyond the first bifurcation in a lobe of the lung) and which can occlude a bronchial passage at that point. An inner catheter is usually introduced through the isolation catheter and used in cooperation with the isolation catheter for delivering and/or removing drugs or washing liquids from the isolated lung region. Optionally, the inner catheter will also have an occluding member near its distal end for further isolation of a target region within the lung.Type: GrantFiled: October 21, 1999Date of Patent: June 4, 2002Assignee: PulmonxInventors: Rodney A. Perkins, Peter P. Soltesz, Robert Kotmel